ADAI News & Events
February 27, 2026
New ADAI Report: Evaluation of Seattle City Ordinance 126896 (Possession and Use of Controlled Substances in Public Spaces)
In late 2023, the City of Seattle passed Ordinance 126896, a law intended to reduce jail bookings for public drug use and possession by encouraging police to divert people to services instead of the criminal legal system. Researchers from the University of Washington’s Addictions, Drug & Alcohol Institute, led by Assistant Professor Mandy Owens, PhD,…
February 20, 2026
Northwest ATTC & CERP Webinar: Integrating Cannabis Use Prevention and Treatment into Primary Care (March 25, 12pm PT)
Join the Northwest ATTC and the Cannabis Education & Research Program (CERP) at ADAI for this timely and informative webinar about cannabis! Integrating Cannabis Use Prevention and Treatment into Primary CareMarch 25, 2026 | 12-1pm PT | Register here Cannabis is one of the most widely used substances in the U.S., with notable rises in…
February 11, 2026
Northwest ATTC Webinar: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (Feb. 25, 2026; CME available!)
Join the Northwest ATTC at ADAI, the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for their next joint webinar, February 25, 2026, 11am-12:30pm PT! In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine…
February 10, 2026
RECORDING AVAILABLE: ADAI CEDEER Webinar: Franklin St. Harm Reduction Center: Community Partnerships in Olympia, WA
This webinar was hosted in February 2026. Find the recording here! Partnerships are powerful! Learn more about how community organizations came together to improve health in Olympia in the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER)‘s next webinar, February 23, 2026, 1-2pm PT. The Franklin St. Harm Reduction Center in Olympia, WA…
February 3, 2026
ADAI Lunch & Learn: Update on Neuromodulation Techniques and Applications (Feb. 26, 2026, 12pm PT)
Join ADAI on February 26, 2026 (12-1pm PT) for the next session in our (virtual) Lunch & Learn series! In this session, Randall Espinoza, MD, MPH, Medical Director of the UW Garvey Institute Center for Neuromodulation, will explore current FDA-approved neuromodulation devices—medical technologies that use electrical pulses, magnetic fields, or other techniques to treat various…
February 2, 2026
Center for Novel Therapeutics in Addiction Psychiatry (NTAP) Joins ADAI!
ADAI is pleased to announce that the UW Center for Novel Therapeutics in Addiction Psychiatry (NTAP) has joined our institute! NTAP’s mission is to “create powerful news ways of treating people struggling with alcohol, opioid, tobacco, and other addictions by combining psychedelic compounds with evidence-based behavioral interventions.” One of their current studies, for example, is…
January 30, 2026
RECORDING AVAILABLE: ADAI Lunch & Learn: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder
This session was hosted in January 2026. Find the recording here! Kevin Coffey, PhD, is a Research Assistant Professor in UW Psychiatry and Behavioral Sciences and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making. Dr. Coffey’s current focus is on…
January 29, 2026
RECORDING AVAILABLE: Washington Community Drug Checking Network (Jan. 27, 2026, 11am PT)
Update: This event was held on January 27, 2026. The slides & recording are now available. Join ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) for the first Washington State Community Drug Checking Network (CDCN) webinar of 2026! This session will provide an overview of the network and its role in supporting drug…
January 27, 2026
ADAI in the News: People with Psychotic Disorders Link Cannabis Use to Physical Ills (UW Medicine News & KUOW)
People who have psychotic disorders, such as schizophrenia, and who also use cannabis report experiencing a wider range of health problems than previously documented. In a study recently described in a paper in Community Mental Health Journal, ADAI Research Associate Professor Beatriz Carlini, PhD, MPH, and colleagues analyzed survey responses from 4,144 Washington State cannabis…
January 22, 2026
New ADAI Publications on Cannabis, Workforce Development, and Treatment Services in Carceral Settings
Here’s what our faculty and staff have been up to lately: People with psychotic disorders are the most vulnerable to cannabis adverse health outcomes: A study in WA State, USA. Carlini BH, Williams JR, Garrett SB, Hammond D. Community Mental Health Journal 2026 (in press). This paper describes a study that compared negative health effects…
Next page
